vimarsana.com

Latest Breaking News On - Healthcare company profile - Page 15 : vimarsana.com

HCA Healthcare (NYSE:HCA) Rating Reiterated by Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of HCA Healthcare (NYSE:HCA – Free Report) in a report issued on Tuesday, Benzinga reports. They currently have a $335.00 target price on the stock. Several other research analysts have also recently issued reports on the stock. Oppenheimer reissued an outperform rating and set a $315.00 price […]

Definitive Healthcare (NASDAQ:DH) Updates Q1 Earnings Guidance

Definitive Healthcare (NASDAQ:DH – Get Free Report) issued an update on its first quarter earnings guidance on Wednesday morning. The company provided EPS guidance of $0.07-0.08 for the period, compared to the consensus EPS estimate of $0.07. The company issued revenue guidance of $63-65 million, compared to the consensus revenue estimate of $65.95 million. Definitive […]

Vinva Investment Management Ltd Grows Holdings in HCA Healthcare, Inc (NYSE:HCA)

Vinva Investment Management Ltd grew its stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 6.1% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,864 shares of the company’s stock after purchasing an additional 392 shares during the quarter. Vinva Investment Management […]

Eagle Asset Management Inc Purchases 54,590 Shares of Definitive Healthcare Corp (NASDAQ:DH)

Eagle Asset Management Inc Purchases 54,590 Shares of Definitive Healthcare Corp (NASDAQ:DH)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

HCA Healthcare, Inc (NYSE:HCA) Given Average Rating of Moderate Buy by Brokerages

HCA Healthcare, Inc. (NYSE:HCA – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are currently covering the firm, MarketBeat reports. Four investment analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 1-year price objective […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.